ID.1
Item
to be included in this study, you must meet the following criteria:
boolean
ID.2
Item
female patients with adenocarcinoma of the breast confirmed by biopsy
boolean
C0079399 (UMLS CUI [1,1])
C0019638 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
ID.3
Item
age 65 or older
boolean
C0001779 (UMLS CUI [1])
ID.4
Item
under age 65 must have significant medical illness, or general frailty
boolean
C0205082 (UMLS CUI [1,1])
C0221423|C0424594 (UMLS CUI [1,2])
ID.5
Item
adequate bone marrow, liver or kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
ID.6
Item
normal heart function
boolean
C0232164 (UMLS CUI [1])
ID.7
Item
less than 84 days from mastectomy/lumpectomy or axillary dissection
boolean
C3714726 (UMLS CUI [1])
ID.8
Item
signed consent obtained prior to initiation of any study procedures
boolean
C0021430 (UMLS CUI [1])
ID.9
Item
you cannot participate in this study if any of the following apply to you:
boolean
ID.10
Item
received neo-adjuvant therapy
boolean
C0600558 (UMLS CUI [1])
ID.11
Item
primary tumor is locally advanced at diagnosis
boolean
C0205179 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
ID.12
Item
received prior chemotherapy within five years
boolean
C1514457 (UMLS CUI [1])
ID.13
Item
received previous radiation therapy within 5 years
boolean
C1522449 (UMLS CUI [1])
ID.14
Item
peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
ID.15
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean